Emerging Technologies

Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for Part 2 of the Emerging Technologies series to discuss the company's thin-film electrode technology.

The CEO of NeuroOne, Dave Rosa, discusses the company's minimally invasive brain-computer interface thin-film, flexible electrode technology, its successes in patients with seizures and the potential benefits across a range of neurological conditions.

In Part 1 of Season 2 of MobiHealthNews’ Emerging Technologies series, Mark Zhang, acting assistant under secretary for health, explains how innovation is scaling across the VA.

Acting assistant under secretary for health at the U.S. Department of Veterans Affairs at the U.S. Department of Veterans Affairs, Dr. Mark Zhang, discusses the VA's research into 3D-printed biological material for veterans.

Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, says Sky Labs CEO Jack Byunghwan Lee.

The British company, which reached a $2.1 billion valuation just a year ago, allows text to be turned into clinical compliance and training videos using AI avatars.

Carlsmed's cofounder, president and CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss how the company uses patient imaging and 3D printing to create personalized spine implants for surgery.

Amy Tucker of Advocate Health's Sanger Heart & Vascular Institute explains what it takes to move to a scalable platform that improves clinical administration and patient care.

Michael Abrams of Numerof and Associates says that oversight for AI used in mental health care should mirror that of pharmaceuticals, with clear standards, safety testing and ongoing monitoring.

The San Francisco-based lab will house Eli Lilly experts in biology, science and medicine alongside NVIDIA AI model builders and engineers.